We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

238 hedge funds and large institutions have $1.57B invested in Supernus Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 85 increasing their positions, 94 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,075% more call options, than puts

Call options by funds: $611K | Put options by funds: $52K

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.77% less ownership

Funds ownership: 105.13% → 104.37% (-0.77%)

10% less repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 94

4% less funds holding

Funds holding: 249 → 238 (-11)

9% less capital invested

Capital invested by funds: $1.72B → $1.57B (-$151M)

29% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 31

Holders
238
Holders Change
-11
Holders Change %
-4.42%
% of All Funds
3.78%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
85
Reduced
94
Closed
31
Calls
$611K
Puts
$52K
Net Calls
+$559K
Net Calls Change
-$1.64M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$8.73M
2
Macquarie Group
Macquarie Group
Australia
+$7.53M
3
BlackRock
BlackRock
New York
+$6.68M
4
PCH
Polar Capital Holdings
United Kingdom
+$4.57M
5
CAM
Congress Asset Management
Massachusetts
+$4.48M

Top Sellers

Rank Fund Capital Flow
1
Pacer Advisors
Pacer Advisors
Pennsylvania
-$13.7M
2
Two Sigma Investments
Two Sigma Investments
New York
-$5.79M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$3.54M
4
BC
Burney Company
Virginia
-$3.49M
5
IBT
International Biotechnology Trust
United Kingdom
-$2.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
Voloridge Investment Management
51
Voloridge Investment Management
Florida
$2.83M +$2.18M +71,744 +233%
HSA
52
Hussman Strategic Advisors
Maryland
$2.58M – – –
New York State Teachers Retirement System (NYSTRS)
53
New York State Teachers Retirement System (NYSTRS)
New York
$2.44M -$15.2K -500 -0.6%
BC
54
Bruce & Co
Illinois
$2.26M – – –
Connor, Clark & Lunn Investment Management (CC&L)
55
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.22M +$742K +24,365 +43%
Envestnet Asset Management
56
Envestnet Asset Management
Illinois
$2.19M -$124K -4,078 -5%
Millennium Management
57
Millennium Management
New York
$2.16M -$1.68M -55,270 -41%
State of New Jersey Common Pension Fund D
58
State of New Jersey Common Pension Fund D
New Jersey
$2.15M +$178K +5,854 +8%
American Century Companies
59
American Century Companies
Missouri
$2.11M +$120K +3,932 +5%
BC
60
Burney Company
Virginia
$1.98M -$3.49M -114,648 -62%
Public Sector Pension Investment Board (PSP Investments)
61
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.86M -$889K -29,219 -30%
Two Sigma Investments
62
Two Sigma Investments
New York
$1.85M -$5.79M -190,195 -74%
BCC
63
Bridge City Capital
Oregon
$1.8M +$75.2K +2,469 +4%
Prudential Financial
64
Prudential Financial
New Jersey
$1.79M -$100K -3,285 -5%
Federated Hermes
65
Federated Hermes
Pennsylvania
$1.78M +$298K +9,776 +18%
IP
66
Isthmus Partners
Wisconsin
$1.78M +$56.6K +1,858 +3%
AllianceBernstein
67
AllianceBernstein
Tennessee
$1.73M – – –
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$1.68M +$3.74K +123 +0.2%
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$1.63M -$158K -5,186 -8%
HF
70
HRT Financial
New York
$1.56M +$1.07M +35,145 +163%
Barclays
71
Barclays
United Kingdom
$1.51M +$31.1K +1,021 +2%
RPCONE
72
Retirement Planning Company of New England
Rhode Island
$1.42M +$720K +23,656 +85%
First Trust Advisors
73
First Trust Advisors
Illinois
$1.41M +$498K +16,372 +47%
Stifel Financial
74
Stifel Financial
Missouri
$1.41M +$301K +9,890 +24%
CS
75
Credit Suisse
Switzerland
$1.4M -$88.5K -2,906 -5%
1 2
3
4 5

SUPN Hedge Fund Activity: Q3 2023 in Review

238 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q3 2023, worth a combined $1.57B — down 8.8% from $1.72B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of SUPN and 22 opened new positions — a net loss of 9 holders — while 94 trimmed existing stakes and 85 added.

The largest buyer was Citadel Advisors, adding an estimated $8.73M. The largest seller was Pacer Advisors, cutting an estimated $13.7M.

  • 238 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q3 2023, down from 249 in Q2 2023.
  • Funds reported $1.57B of Supernus Pharmaceuticals stock for Q3 2023, down 8.8% quarter-over-quarter.
  • 22 funds opened new Supernus Pharmaceuticals positions in Q3 2023 and 31 closed out, a net change of -9 holders.
  • The largest Supernus Pharmaceuticals buyer in Q3 2023 was Citadel Advisors, an estimated $8.73M added.
  • The largest Supernus Pharmaceuticals seller in Q3 2023 was Pacer Advisors, an estimated $13.7M sold.

Based on aggregated 13F filings for Q3 2023.